These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 8477146)

  • 1. Mental health in nursing homes. Perspectives on the use of medication.
    Snowdon J
    Drugs Aging; 1993; 3(2):122-30. PubMed ID: 8477146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dementia and use of psychotropic medication in non-'Elderly Mentally Infirm' nursing homes in South East England.
    Macdonald AJ; Carpenter GI; Box O; Roberts A; Sahu S
    Age Ageing; 2002 Jan; 31(1):58-64. PubMed ID: 11850309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychotropic and anti-dementia treatment in elderly persons with clinical signs of dementia with Lewy bodies: a cross-sectional study in 40 nursing homes in Sweden.
    Zahirovic I; Torisson G; Wattmo C; Londos E
    BMC Geriatr; 2018 Feb; 18(1):50. PubMed ID: 29454305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychotropic drug use in nursing homes--diagnostic indications and variations between institutions.
    Ruths S; Straand J; Nygaard HA
    Eur J Clin Pharmacol; 2001 Sep; 57(6-7):523-8. PubMed ID: 11699620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of psychotropics in Sydney nursing homes: associations with depression, psychosis, and behavioral disturbances.
    Draper B; Brodaty H; Low LF; Saab D; Lie D; Richards V; Paton H
    Int Psychogeriatr; 2001 Mar; 13(1):107-20. PubMed ID: 11352328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychotropic drugs in nursing- and old-age homes: relationships between needs of care and mental health status.
    Holmquist IB; Svensson B; Höglund P
    Eur J Clin Pharmacol; 2003 Nov; 59(8-9):669-76. PubMed ID: 14517706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychotropic medication use in Swiss nursing homes.
    Lustenberger I; Schüpbach B; von Gunten A; Mosimann U
    Swiss Med Wkly; 2011; 141():w13254. PubMed ID: 21971698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological treatment of behavioral and psychological symptoms of dementia (BPSD) in nursing homes: development of practice recommendations in a Swiss canton.
    Locca JF; Büla CJ; Zumbach S; Bugnon O
    J Am Med Dir Assoc; 2008 Jul; 9(6):439-48. PubMed ID: 18585647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychotropic drug use in Sydney nursing homes.
    Snowdon J; Vaughan R; Miller R; Burgess EE; Tremlett P
    Med J Aust; 1995 Jul; 163(2):70-2. PubMed ID: 7616901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Person-centered, non-pharmacological intervention in reducing psychotropic medications use among residents with dementia in Australian rural aged care homes.
    Parajuli DR; Kuot A; Hamiduzzaman M; Gladman J; Isaac V
    BMC Psychiatry; 2021 Jan; 21(1):36. PubMed ID: 33441109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Gerontopsychiatric competence is in demand. The current psychopharmacologic treatment practice in homes for the aged and nursing homes].
    Riedel-Heller SG; Stelzner G; Schork A; Angermeyer MC
    Psychiatr Prax; 1999 Nov; 26(6):273-6. PubMed ID: 10627955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prescribing psychoactive medications in nursing homes: current practice in Singapore.
    Mamun K; Goh-Tan CY; Ng LL
    Singapore Med J; 2003 Dec; 44(12):625-9. PubMed ID: 14770256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of psychotropic medications for persons with mental retardation who live in Oklahoma nursing homes.
    Spreat S; Conroy J
    Psychiatr Serv; 1998 Apr; 49(4):510-2. PubMed ID: 9550242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of psychopharmaceuticals in municipal nursing homes. A nationwide survey].
    Tybjerg J; Gulmann NC
    Ugeskr Laeger; 1992 Nov; 154(45):3126-9. PubMed ID: 1462408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An effective approach to decrease antipsychotic and benzodiazepine use in nursing homes: the RedUSe project.
    Westbury J; Jackson S; Gee P; Peterson G
    Int Psychogeriatr; 2010 Feb; 22(1):26-36. PubMed ID: 19814843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mental illness and psychotropic medication use in the nursing home.
    Arling G; Ryther BJ; Collins T; Zimmerman D
    J Aging Health; 1991 Nov; 3(4):455-72. PubMed ID: 10115034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Determinants of psychotropic drug utilization in homes for the elderly and in nursing homes].
    Stelzner G; Riedel-Heller SG; Sonntag A; Matschinger H; Jakob A; Angermeyer MC
    Z Gerontol Geriatr; 2001 Aug; 34(4):306-12. PubMed ID: 11584715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes to psychotropic medications in the six months after admission to nursing homes in Melbourne, Australia.
    O'Connor DW; Griffith J; McSweeney K
    Int Psychogeriatr; 2010 Nov; 22(7):1149-53. PubMed ID: 20199701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The prevalence of psychiatric diagnoses and psychotropic medication in icelandic nursing homes from 2003 to 2018].
    Biering P; Hjaltadottir I
    Laeknabladid; 2021 Jan; 107(1):11-16. PubMed ID: 33350394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current prevalence of dementia, depression and behavioural problems in the older adult care home sector: the South East London Care Home Survey.
    Stewart R; Hotopf M; Dewey M; Ballard C; Bisla J; Calem M; Fahmy V; Hockley J; Kinley J; Pearce H; Saraf A; Begum A
    Age Ageing; 2014 Jul; 43(4):562-7. PubMed ID: 24855111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.